Cargando…
Modification of STIM2 by m(6)A RNA methylation inhibits metastasis of cholangiocarcinoma
BACKGROUND: N6-methyladenosine (m(6)A) is the most frequent internal methylation of eukaryotic RNA (ribonucleic acid) transcripts and plays an important function in RNA processing. The current research aimed to investigate the role of m(6)A-STIM2 axis in cholangiocarcinoma (CCA) progression. METHODS...
Autores principales: | Chen, Feng-Qiu, Zheng, Hao, Gu, Ting, Hu, Yu-Hua, Yang, Le, Huang, Zhi-Ping, Qiao, Guang-Lei, Li, Hong-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848379/ https://www.ncbi.nlm.nih.gov/pubmed/35282134 http://dx.doi.org/10.21037/atm-21-6485 |
Ejemplares similares
-
Erratum to modification of STIM2 by m(6)A RNA methylation inhibits metastasis of cholangiocarcinoma
Publicado: (2022) -
CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m(6)A) modification
por: Zhou, Shurui, et al.
Publicado: (2023) -
STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma
por: Zhao, Huakan, et al.
Publicado: (2020) -
N(6)-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone Metastasis
por: Zheng, Hao, et al.
Publicado: (2023) -
Analysis of m6A Methylation Modification Patterns and Tumor Immune Microenvironment in Breast Cancer
por: Dong, Menglu, et al.
Publicado: (2022)